Around 5,000 blood cancer patients could benefit from 13 treatments recommended by NICE in 2024. This is the largest number of positive recommendations in a single year for blood cancer treatments.

Researchers from City of Hope develop test using machine learning to predict immunotherapy response in lymphoma patients: Los Angeles Wednesday, April 2, 2025, 12:00 Hrs [IST] Res ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.

The death of former England footballer Trevor Whymark may have been linked to heading the ball during his professional career ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

Researchers from the City of Hope and Memorial Sloan Kettering (MSK) Cancer Center, US, have developed a tool named ...

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States ...

Experts discuss how the 5-year outcomes of polatuzumab have influenced its position in current NCCN guidelines for diffuse ...

Experts discuss the 5-year efficacy and safety outcomes of polatuzumab in diffuse large B-cell lymphoma (DLBCL), highlighting ...

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

Rising leukemia rates in Florida linked to aging population, new treatment guidelines for follicular lymphoma, a new study that may help unlock immunotherapy for glioblastoma, and more are in this ...